1) Raut CP, et al : Retroperitoneal Sarcomas : Combined-Modality Treatment Approaches. J Surg Oncol 94 : 81-87, 2006
2) NCCN Clinical Practice Guidelines in Oncology Soft Tissue Sarcoma Ver 4.2019-September 12, 2019
3) Tan MC, et al : Surgical Management of Retroperitoneal and Pelvic Sarcomas. J Surg Oncol 111 : 553-561, 2015
4) Trans-Atlantic RPS Working Group : Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult : A Consensus Approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 22 : 256-263, 2015
5) MacNeill AJ, et al : Post-Relapse Outcomes After Primary Extended Resection of Retroperitoneal Sarcoma : A Report from the Trans-Atlantic RPS Working Group. Cancer 123 : 1971-1978, 2017
6) Datta J, et al : Contemporary Reappraisal of the Efficacy of Adjuvant Chemotherapy in Resected Retroperitoneal Sarcoma : Evidence from a Nationwide Clinical Oncology Database and Review of the Literature. Surg Oncol 26 : 117-124, 2017
7) Le Pechoux C, et al : Should Adjuvant Radiotherapy Be Administered in Addition to Front-Line Aggressive Surgery (FAS) in Patients with Primary Retroperitoneal Sarcoma? Ann Oncol 24 : 823-827, 2013
8) Antman K, et al : An Intergroup Phase III Randomized Study of Doxorubicin and Dacarbazine with or without Ifosfamide and Mesna in Advanced Soft Tissue and Bone Sarcomas. J Clin Oncol 11 : 1276-1285, 1993
9) Italiano A, et al : Advanced Well-Differentiated/Dedifferentiated Liposarcomas : Role of Chemotherapy and Survival. Ann Oncol 23 : 1601-1607, 2012
10) Judson I, et al : Doxorubicin Alone Versus Intensified Doxorubicin Plus Ifosfamide for First-Line Treatment of Advanced or Metastatic Soft-Tissue Sarcoma : A Randomised Controlled Phase 3 Trial. Lancet Oncol 15 : 415-423, 2014
11) Seddon B, et al : Gemcitabine and Docetaxel Versus Doxorubicin as First-Line Treatment in Previously Untreated Advanced Unresectable or Metastatic Soft-Tissue Sarcomas (GeDDiS) : A Randomized Controlled Phase 3 Trial. Lancet Oncol 18 : 1397-1410, 2017
12) Schöffski P, et al : Eribulin Versus Dacarbazine in Previously Treated Patients with Advanced Liposarcoma or Leiomyosarcoma : A Randomised, Open-Label, Multicentre, Phase 3 Trial. Lancet 387 : 1629-1637, 2016
13) Demetri GD, et al : Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy : Results of a Phase III Randomized Multicenter Clinical Trial. J Clin Oncol 34 : 786-793, 2016
14) Van der Graaf WT, et al : Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE) : A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial. Lancet 379 : 1879-1886, 2012
15) Sleijfer S, et al : Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients with Relapsed or Refractory Advanced Soft Tissue Sarcoma : A Phase II Study from the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043). J Clin Oncol 273 : 3126-3132, 2009
16) Dickson MA, et al : Progression Free Survival Among Patients with Well-Differentiated or Dedifferentiated Liposarcoma : A Phase 2 Clinical Trail CDK4 Inhibitor Palbociclib. JAMA Oncol 2 : 937-940, 2016